A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes

NCT05890950 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Type 2 Diabetes Mellitus in Obese

Interventions

DRUG: K-757 and K-833
DRUG: Matching placebo to K-757 and K-833

Sponsor

Kallyope Inc.